Anji Pharmaceuticals is focused on tackling high-value targets validated by human genetics. Founded by Yiwei Zong in 2018Anji Pharmaceuticals is backed by Viva Ventures Biotech Fund, Xiamen Changrong Investment Management, and JMCR Partners and is headquartered in Cambridge.